Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

BIOT

BIOTECH ACQUISITION COMPANY

BIOT

BIOT (BIOTECH ACQUISITION COMPANY) is held by 0 institutional investors as of Q1 2023.

No verdict yet — fewer than 2 funds hold BIOT.

Top Holders

Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available
Checking access…
Action
Exited
0(-100.0%)$1.7M0.0%—
0
Exited
0(-100.0%)$3M0.0%—
0
Exited
0(-100.0%)$2.5M0.0%—
0
Exited
0(-100.0%)$3.8M0.0%—
0
Exited
0(-100.0%)$610,6360.0%—
0
Exited
0(-100.0%)$3.6M0.0%—
0
Exited
0(-100.0%)$802,7400.0%—
0
Exited
0(-100.0%)$252,4750.0%—
0
Exited
0(-100.0%)$1.2M0.0%—
0
Exited
0(-100.0%)$4M0.0%—
0
Exited
0(-100.0%)$1M0.0%—
0
Exited
0(-100.0%)$1.5M0.0%—
0
Exited
0(-100.0%)$2.5M0.0%—
0
Exited
0(-100.0%)$422,5980.0%—
0
Exited
0(-100.0%)$404,0770.0%—
0
Exited
0(-100.0%)$7.1M0.0%—
0
Exited
0(-100.0%)$12.7M0.0%—
0
Exited
0(-100.0%)$505,0000.0%—
0
Exited
0(-100.0%)$1.4M0.0%—
0
Exited
0(-100.0%)$9.7M0.0%—
0

Showing 1-20 of 27

1 / 2
Loading insider trades…
Loading Congress trades…
Loading activist filings…
BIOTBIOTBIOTECH ACQUISITION COMPANY

Similar stocks

Questions investors ask about BIOT

Who owns BIOT?

0 institutional investors held BIOT on March 31, 2023, according to their 13F filings.

How many hedge funds hold BIOT?

0 institutional investors reported BIOT in their 13F filings for the quarter ended March 31, 2023.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used